Skip to Content

Clinical Trials Detail

GOG 0244: The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors and Impact in Newly Diagnosed Patients

Objective
This is a clinical trial designated to learn more about how often women with your type of cancer may develop lower extremity lymphedema (swelling in the legs or a swollen leg) after undergoing surgery to remove your tumor and surrounding tissue for gynecologic cancer.
IRB Protocol Number
13-1706
Principal Investigator(s)
SUSAN DAVIDSON

Cancer Trials

  • Female Reproductive Cancer
Sponsor(s)
GOG
Contact
REBECCA KISSANE at 720-848-7202
or REBECCA.KISSANE@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : A screening period will determine eligibility. Treatment period can last up to 2 years. A follow up period will consist of an examination 4-6 weeks after surgery, then every three months during months 3-12, and every 6 months during months13-24. // Eligibility criteria include but are not limited to 18 years or older with cervical, vulvar, or uterine cancer.